Digital fluoroscopy to quantify lung tumor motion: potential for patient-specific planning target volumes.
暂无分享,去创建一个
Mark Ruschin | M. Ruschin | K. Sixel | R. Tirona | P. Cheung | Katharina E Sixel | Romeo Tirona | Patrick C F Cheung
[1] J. Purdy,et al. Three-dimensional conformal radiotherapy in bronchogenic carcinoma: considerations for implementation. , 1994, Lung cancer.
[2] A. Juretić,et al. Combined modality therapy of non-small cell lung cancers. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] A Harvey,et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] C. Ling,et al. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. , 2000, Cancer journal.
[5] R K Ten Haken,et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Ciezki,et al. Fluoroscopic study of tumor motion due to breathing: facilitating precise radiation therapy for lung cancer patients. , 2001, Medical physics.
[7] P. Maguire,et al. 73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] S. Korfee,et al. Lung cancer: Combined modality therapy in NSCLC , 2000 .
[9] B. Freidlin,et al. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] R. Jaszczak,et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. , 2001, International journal of radiation oncology, biology, physics.
[11] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J C Rosenwald,et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.
[13] J C Rosenwald,et al. Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing. , 2001, International journal of radiation oncology, biology, physics.
[14] H. Bartelink,et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.
[15] W. Stanford,et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. , 1990, International journal of radiation oncology, biology, physics.
[16] W. Curran,et al. Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group , 2000 .
[17] Mark Ruschin,et al. Integration of digital fluoroscopy with CT-based radiation therapy planning of lung tumors. , 2002, Medical physics.
[18] T. Lynch,et al. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] James A. Purdy,et al. 3-D Conformal Radiotherapy for Lung Cancer , 1996 .
[20] J. Herndon,et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. , 1996, Journal of the National Cancer Institute.
[21] D. Joseph,et al. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] B. Murray,et al. Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices. , 1999, International journal of radiation oncology, biology, physics.
[23] M. Kris,et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] C. Ling,et al. Respiration-correlated spiral CT: a method of measuring respiratory-induced anatomic motion for radiation treatment planning. , 2002, Medical physics.